呼吸肌代谢活动与肺癌术后阻塞性通气障碍严重程度及预后相关
BACKGROUND AND OBJECTIVE: Respiratory muscle activity is increased in patients with chronic respiratory disease. 18 F-FDG-PET/CT can assess respiratory muscle activity.…
要点
- 呼吸肌FDG摄取与FEV1负相关,提示代谢活性反映通气障碍严重程度。
- 呼吸肌高代谢患者总生存期更差,调整FEV1%后仍有预后意义。
- PET/CT可评估呼吸肌活性并识别肺癌手术高危患者。
核心结论
- 呼吸肌高代谢与肺功能损害相关,并具有预后价值。
- 18F-FDG-PET/CT可作为评估呼吸肌活性及识别高危患者的工具。
研究设计与样本
- 在胸锁乳突肌、斜角肌、肋间肌、膈肌测量SUVm,并以三角肌SUVm标准化。
- 呼吸肌高代谢定义为任一呼吸肌组SUVm>第90百分位。
- 临床结局来自前瞻性队列。
主要发现
- 斜角肌SUVm为1.84[1.51-2.25],胸锁乳突肌1.64[1.34-1.95],肋间肌1.01[0.84-1.16],膈肌1.79[1.41-2.27]。
- 斜角肌摄取与FEV1负相关(r=-0.29,p<0.001),胸锁乳突肌与FEV1负相关(r=-0.17,p=0.03)。
- 斜角肌摄取与TLC正相关(r=0.17,p=0.04)。
- 45例(28.8%)存在呼吸肌高代谢,其VO2 max较低(15.4[14.2-17.5] vs. 17.2 mL/kg/min[15.2-21.1],p=0.07)。
- 调整FEV1%后,呼吸肌高代谢与更差的总生存期相关(p<0.01)。
关键数值与推荐
- 呼吸肌高代谢定义为任一呼吸肌组SUVm>第90百分位。
- SUVm以三角肌SUVm进行标准化。
临床怎么用
- 肺癌术前PET/CT可评估呼吸肌代谢,辅助识别肺功能受损及预后不良的高危患者。
局限性
- 样本量有限,单中心设计可能影响外推性。
- 呼吸肌高代谢组VO2 max差异仅达临界统计学意义(p=0.07)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Respiratory muscle activity is increased in patients with chronic respiratory disease. 18 F-FDG-PET/CT can assess respiratory muscle activity. We hypothesized that respiratory muscles metabolism was correlated to lung function impairment and was associated to prognosis in patients undergoing lung cancer surgery based on the research question whether respiratory muscle metabolism quantitatively correlates with the severity of lung function impairment in patients? Does respiratory muscle hypermetabolism have prognostic value? METHODS: Patients undergoing 18 F-FDG-PET/CT and pulmonary function tests prior to lung cancer surgery were identified. Maximum Standardized Uptake Value (SUVm) were measured in each respiratory muscle group (sternocleidomastoid, scalene, intercostal, diaphragm), normalized against deltoid SUVm. Respiratory muscle hypermetabolism was defined as SUVm >90th centile in any respiratory muscle group. Clinical outcomes were collected from a prospective cohort. RESULTS: One hundred fifty-six patients were included, mostly male [110 (71%)], 53 (34%) with previous diagnosis of COPD. Respiratory muscle SUVm were: scalene: 1.84 [1.51-2.25], sternocleidomastoid 1.64 [1.34-1.95], intercostal 1.01 [0.84-1.16], diaphragm 1.79 [1.41-2.27]. Tracer uptake was inversely correlated to FEV1 for the scalene (r = -0.29, p < 0.001) and SCM (r = -0.17, p = 0.03) respiratory muscle groups and positively correlated to TLC for the scalene (r = 0.17, p = 0.04). Respiratory muscle hypermetabolism was found in 45 patients (28.8%), who had a lower VO2 max (15.4 [14.2-17.5] vs. 17.2 mL/kg/min [15.2-21.1], p = 0.07) and poorer overall survival when adjusting to FEV1% (p < 0.01). CONCLUSION: Our findings show respiratory muscle hypermetabolism is associated with lung function impairment and has prognostic significance. 18 F-FDG/PET-CT should be considered as a tool for assessing respiratory muscle activity and to identify high-risk patients.
引用
- El Husseini K, Baste JM, Bouyeure-Petit AC, et al. Respiratory muscle metabolic activity on PET/CT correlates with obstructive ventilatory defect severity and prognosis in patients undergoing lung cancer surgery. Respirology. 2023. PMID: 36855939. doi:10.1111/resp.14475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。